Timelines and Key Planning Considerations
Herspiegel has been working with many pharmaceutical partners to help prepare for and understand the various guidance released by The Centers for Medicare and Medicaid Services (CMS). Given the IRA will make many new improvements to the Medicare program overall, bringing innovative, life-saving treatments to patients, many on the pharmaceutical side have been mainly focused on preparing for the Medicare Drug Price Negotiation Program. Download this paper to understand the current timelines and guidance and planning considerations.
Download the White Paper Now
"*" indicates required fields
